Vanguard Group Inc Sensei Biotherapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 594,454 shares of SNSE stock, worth $285,337. This represents 0.0% of its overall portfolio holdings.

Number of Shares

594,454

Previous 618,757 3.93%

Holding current value

$285,337

Previous $371,000 19.95%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$0.41 - $0.78 $9,964 - $18,956	-24,303 Reduced 3.93%	594,454 $297,000
Q2 2024 Aug 13, 2024	BUY	$0.59 - $1.84 $26,498 - $82,639	44,913 Added 7.83%	618,757 $383,000
Q1 2024 May 10, 2024	BUY	$0.73 - $1.17 $140 - $225	193 Added 0.03%	573,844 $602,000
Q4 2022 Feb 10, 2023	BUY	$1.33 - $1.74 $259 - $339	195 Added 0.03%	573,651 $854,000
Q3 2022 Nov 14, 2022	SELL	$1.55 - $2.24 $148,979 - $215,299	-96,116 Reduced 14.35%	573,456 $889,000
Q2 2022 Aug 12, 2022	SELL	$1.49 - $2.3 $128,703 - $198,669	-86,378 Reduced 11.43%	669,572 $1.52 Million
Q1 2022 May 13, 2022	BUY	$2.22 - $6.07 $5,006 - $13,687	2,255 Added 0.3%	755,950 $1.75 Million
Q4 2021 Feb 14, 2022	BUY	$4.85 - $10.48 $33,639 - $72,689	6,936 Added 0.93%	753,695 $4.37 Million
Q3 2021 Nov 12, 2021	BUY	$6.89 - $11.99 $2.47 Million - $4.3 Million	359,006 Added 92.59%	746,759 $7.86 Million
Q2 2021 Aug 13, 2021	BUY	$9.1 - $15.14 $3.53 Million - $5.87 Million	387,753 New	387,753 $3.78 Million

Others Institutions Holding SNSE

# of Institutions

Shares Held

2.39M

Call Options Held

Put Options Held

View Full List

About Sensei Biotherapeutics, Inc.

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $14.7M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

More about SNSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Sensei Biotherapeutics, Inc. Transaction History